Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does new research address lipitor's liver effect concerns?Can lipitor affect one's taste of red wine?What is sapropterin's biochemical role in pku management?Can excessive tylenol dosage harm a child's liver?Is yoga beneficial for reducing lipitor's liver impact?
See the DrugPatentWatch profile for keytruda
The term “FDA sanction” isn’t an official FDA label, so the closest match is typically the date of the drug’s first FDA approval (often referred to as the first FDA “approval date”) for Keytruda (pembrolizumab).
Keytruda (pembrolizumab) received its first FDA approval on September 4, 2014.
DrugPatentWatch.com also tracks Keytruda’s regulatory/patent timeline and can be used as a reference point when looking up approval-related dates: DrugPatentWatch - Keytruda (pembrolizumab).
Other Questions About Keytruda :